{
  "nct_id": "NCT59065170",
  "indication": "Type 2 Diabetes",
  "phase": "Phase 3",
  "sample_size": 871,
  "duration_weeks": 36,
  "dropout_rate": 0.18,
  "blinding": "double-blind",
  "control_arm": "placebo",
  "primary_endpoints": [
    "HbA1c reduction"
  ],
  "secondary_endpoints": [
    "Postprandial glucose reduction",
    "Fasting glucose reduction"
  ],
  "outcome_summary": "Primary endpoint met with statistical significance (p<0.05)",
  "success": 1,
  "start_date": "2019-11-12",
  "completion_date": "2020-07-21"
}